News + Filings Transactions Holdings
|
Invus Public Equities, L.P.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/28/2023 | Scholar Rock Holding Corp | SRRK | Purchase | Common Stock | 31.6k | $6.43 | $202.8k | | 04/28/2023 |
| 02/24/2023 | GLYCOMIMETICS INC | GLYC | Purchase | Common Stock | 100k | $1.70 | $170k | | 02/24/2023 |
| 02/23/2023 | GLYCOMIMETICS INC | GLYC | Purchase | Common Stock | 200k | $1.75 | $350.8k | | 02/21/2023 |
| 02/22/2023 | GLYCOMIMETICS INC | GLYC | Purchase | Common Stock | 150k | $1.79 | $269k | | 02/21/2023 |
| 02/21/2023 | GLYCOMIMETICS INC | GLYC | Purchase | Common Stock | 50k | $1.85 | $92.5k | | 02/21/2023 |
| 01/09/2023 | Scholar Rock Holding Corp | SRRK | Sale | Common Stock | 1.1k | $9.48 | $10.4k | | 01/09/2023 |
| 01/05/2023 | Scholar Rock Holding Corp | SRRK | Purchase | Common Stock | 48.8k | $9.33 | $455.1k | | 01/05/2023 |
| 10/25/2022 | Scholar Rock Holding Corp | SRRK | Purchase | Common Stock | 130.3k | $8.04 | $1M | | 10/25/2022 |
| 10/04/2022 | Scholar Rock Holding Corp | SRRK | Purchase | Common Stock | 66k | $7.89 | $520.8k | | 10/03/2022 |
| 10/03/2022 | Scholar Rock Holding Corp | SRRK | Purchase | Common Stock | 34k | $7.03 | $238.8k | | 10/03/2022 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Common Stock | 1.3M | $0.00 | $0 | | 07/30/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 875k | $17.00 | $14.9M | | 07/30/2021 |
| 08/03/2021 | Omega Therapeutics, Inc. | | Conversion | Series C Convertible Preferred Stock | 5M | $0.00 | $0 | | 07/30/2021 |
| 07/30/2021 | Omega Therapeutics, Inc. | | Purchase | Common Stock | 75k | $16.14 | $1.2M | | 07/30/2021 |
| 02/01/2021 | Seer, Inc. | SEER | Sale | Class A Common Stock | 252.5k | $64.15 | $16.2M | | 02/01/2021 |
| 12/16/2020 | LEXICON PHARMACEUTICALS, INC. | LXRX | Purchase | Common Stock | 10.9M | $3.20 | $35M | See Footnotes | 12/16/2020 |
| 12/08/2020 | Seer, Inc. | SEER | Conversion | Series C Convertible Preferred Stock | 373.8k | $0.00 | $0 | | 12/08/2020 |
| 12/08/2020 | Seer, Inc. | SEER | Conversion | Series D Convertible Preferred Stock | 474.5k | $0.00 | $0 | | 12/08/2020 |
| 12/08/2020 | Seer, Inc. | SEER | Conversion | Series D-1 Convertible Preferred Stock | 249.2k | $0.00 | $0 | | 12/08/2020 |
| 12/08/2020 | Seer, Inc. | SEER | Conversion | Class A Common Stock | 5.1M | $0.00 | $0 | | 12/08/2020 |
| 12/08/2020 | Seer, Inc. | SEER | Purchase | Class A Common Stock | 790k | $19.00 | $15M | | 12/08/2020 |
| 12/08/2020 | Seer, Inc. | SEER | Conversion | Series B Convertible Preferred Stock | 4M | $0.00 | $0 | | 12/08/2020 |
| 11/03/2020 | SQZ Biotechnologies Co | SQZ | Conversion | Common Stock | 1.1M | $0.00 | $0 | | 11/03/2020 |
| 11/03/2020 | SQZ Biotechnologies Co | SQZ | Purchase | Common Stock | 465k | $16.00 | $7.4M | | 11/03/2020 |
| 11/03/2020 | SQZ Biotechnologies Co | SQZ | Conversion | Series C Convertible Preferred Stock | 843.5k | $0.00 | $0 | | 11/03/2020 |
| 11/03/2020 | SQZ Biotechnologies Co | SQZ | Conversion | Series D Convertible Preferred Stock | 240.4k | $0.00 | $0 | | 11/03/2020 |
| 06/16/2020 | Generation Bio Co. | GBIO | Conversion | Common Stock | 2M | $0.00 | $0 | | 06/16/2020 |
| 06/16/2020 | Generation Bio Co. | GBIO | Purchase | Common Stock | 800k | $19.00 | $15.2M | | 06/16/2020 |
| 06/16/2020 | Generation Bio Co. | GBIO | Conversion | Series B Preferred Stock | 2.2M | $0.00 | $0 | | 06/16/2020 |
| 06/16/2020 | Generation Bio Co. | GBIO | Conversion | Series C Preferred Stock | 1.1M | $0.00 | $0 | | 06/16/2020 |
| 06/28/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Purchase | Common Stock | 57.7k | $12.45 | $718.9k | See Footnotes | 06/27/2018 |
| 06/27/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Purchase | Common Stock | 125.1k | $12.54 | $1.6M | See Footnotes | 06/27/2018 |
| 06/25/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Purchase | Common Stock | 228.3k | $12.95 | $3M | See Footnotes | 06/22/2018 |
| 06/22/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Purchase | Common Stock | 25.5k | $13.36 | $340.1k | See Footnotes | 06/22/2018 |
| 06/21/2018 | LEXICON PHARMACEUTICALS, INC. | LXRX | Purchase | Common Stock | 51.6k | $13.27 | $684.6k | See Footnotes | 06/19/2018 |
|
|